Prolight Diagnostics AB (publ) (NGM:PRLD)
Sweden · Delayed Price · Currency is SEK 19.94
+0.54 (2.78%)
At close: Sep 24, 2026
Prolight Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 15.35 | 15.35 | 17.23 | 12.57 | - | - |
Other Revenue | 15.29 | 26.85 | 19.09 | 11.64 | 9.04 | 0.11 |
| 30.63 | 42.2 | 36.33 | 24.22 | 9.04 | 0.11 | |
Revenue Growth | -31.10% | 16.16% | 50.02% | 167.90% | 8305.00% | -86.96% |
Gross Profit | 30.63 | 42.2 | 36.33 | 24.22 | 9.04 | 0.11 |
Selling, General & Admin | 84.93 | 75.8 | 62.12 | 45.94 | 47.72 | 7.06 |
Other Operating Expenses | -12.81 | 0.01 | -0.02 | 0.02 | -26.16 | - |
Operating Expenses | 74.46 | 93.61 | 63.6 | 46.73 | 21.69 | 7.06 |
Operating Income | -43.82 | -51.41 | -27.27 | -22.52 | -12.65 | -6.95 |
Interest Expense | - | -0.32 | -0.26 | -0.19 | -0 | - |
Interest & Investment Income | 0.49 | 0.49 | 0.59 | 0.55 | 0.37 | 0.12 |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0.02 |
Other Non Operating Income (Expenses) | -0 | - | -0 | - | - | - |
EBT Excluding Unusual Items | -43.33 | -51.24 | -26.94 | -22.16 | -12.28 | -6.86 |
Asset Writedown | -1.84 | -1.84 | - | -113.3 | - | - |
Pretax Income | -45.17 | -53.08 | -26.94 | -135.46 | -12.28 | -6.86 |
Income Tax Expense | -0.44 | -3.37 | - | - | - | - |
Net Income | -44.73 | -49.71 | -26.94 | -135.46 | -12.28 | -6.86 |
Net Income to Common | -44.73 | -49.71 | -26.94 | -135.46 | -12.28 | -6.86 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 14 | 12 | 6 | 3 | - | 1 |
Shares Outstanding (Diluted) | 14 | 12 | 6 | 3 | - | 1 |
Shares Change | 106.92% | 101.16% | 108.79% | - | - | 10.32% |
EPS (Basic) | -3.11 | -4.18 | -4.56 | -47.90 | - | -4.60 |
EPS (Diluted) | -3.11 | -4.18 | -4.56 | -47.90 | - | -4.60 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -35.19 | -41.39 | -32.85 | -27.35 | -9.99 | -7.2 |
Free Cash Flow Per Share | -2.45 | -3.48 | -5.56 | -9.67 | - | -4.83 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -143.06% | -121.84% | -75.06% | -92.99% | -139.93% | -6464.07% |
Profit Margin | -146.00% | -117.79% | -74.15% | -559.41% | -135.81% | -6374.51% |
Free Cash Flow Margin | -114.88% | -98.07% | -90.42% | -112.96% | -110.54% | -6690.73% |
EBITDA | -57.42 | -49.54 | -25.76 | -21.74 | -12.51 | - |
EBITDA Margin | -187.42% | -117.40% | -70.92% | -89.79% | -138.45% | - |
D&A For EBITDA | -13.59 | 1.87 | 1.51 | 0.78 | 0.13 | - |
EBIT | -43.82 | -51.41 | -27.27 | -22.52 | -12.65 | -6.95 |
EBIT Margin | -143.06% | -121.84% | -75.06% | -92.99% | -139.93% | - |
Revenue as Reported | 43.46 | 42.2 | 36.37 | 24.32 | 35.55 | 0.11 |